{"disease":{"id":"subjects-with-hyperlipidemia-dyslipidemia-and-hiv-infection","name":"subjects with hyperlipidemia dyslipidemia and hiv infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02833844","title":"Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":467,"lead_sponsor_name":"Amgen","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}